NEW DELHI : Union Health Minister Dr Harsh Vardhan on Monday said that the recovery time from COVID-19 infection and oxygen dependency will be reduced by anti-COVID drug 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development Organisation (DRDO).
While speaking at the release ceremony of the first batch of the 2-DG drug, Vardhan said, “With the support of DRDO and in the leadership of Union Defence Minister Rajnath Singh, this (anti-COVID drug 2DG) may be our first indigenous research-based outcome to fight against COVID-19. It will reduce recovery time and oxygen dependency.”
“I hope that this drug will serve the world and not just India in the fight against COVID-19 in the coming days,” he further said.
DRDO s anti-COVID drug 2-DG to reduce recovery time, oxygen dependency: Union Health Minister Harsh Vardhan
The drug comes in powder form in a sachet, which is taken orally by dissolving it in water. It accumulates in the virus-infected cells and prevents virus growth by stopping viral synthesis
Share Via Email
| A+A A-
Defence Minister Rajnath Singh handed over the Anti-COVID drug 2DG to Union Health Minister Dr Harsh Vardhan (Photo | ANI) By ANI
NEW DELHI: Union Health Minister Dr Harsh Vardhan on Monday said that the recovery time from COVID-19 infection and oxygen dependency will be reduced by anti-COVID drug 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development Organisation (DRDO).
India's daily Covid cases dropped below the 3 lakh-mark for the first time since April 21 with 2.81 lakh fresh infections reported in the last 24 hours. 4,106 Covid patients have died since yesterday.
Highlights
Harsh Vardhan on May 17 hoped that DRDO s anti-COVID drug will serve the world and not just India.
Union Health Minister was speaking after the release of the 1st batch of 2-DG by Rajnath Singh.
New Delhi: Union Health Minister Harsh Vardhan on Monday (May 17, 2021) hoped that the DRDO s anti-COVID drug 2-deoxy-D-glucose (2-DG) will serve the world and not just India in the fight against coronavirus.
He said, With the support of DRDO and in the leadership of Union Defence Minister Rajnath Singh, this (anti-COVID drug 2DG) may be our first indigenous research-based outcome to fight against COVID-19. It will reduce recovery time and oxygen dependency.
2:40 PM
The anti-COVID drug 2-deoxy-D-glucose or 2-DG, developed by the Defence Research and Development Organisation, was launched on Monday by Union Defence Minister Rajnath Singh and Health Minister Dr. Harsh Vardhan (DRDO). In the national capital, the two union ministers distributed approximately 10,000 doses of the drug.
The drug 2-DG was developed in partnership with Dr Reddy’s Laboratories by the DRDO. It was approved for emergency use by the Drugs Controller General of India (DCGI) after phase 2 trials found the medication to be safe for treating COVID-19 patients. In Covid-19 infected patients, the 2-DG anti-Covid drug is expected to minimise their reliance on medical oxygen. The drug’s pseudo glucose molecule prevents the virus from infecting the intestines. As a result, it’s been recommended for Coronavirus-infected patients who need life-saving medical oxygen.